- Home
- ACNB vs OBIO Comparison
ACNB vs OBIO Comparison
Compare ACNB & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACNB
- OBIO
- Stock Information
- Founded
- ACNB 1857
- OBIO 2017
- Country
- ACNB United States
- OBIO United States
- Employees
- ACNB N/A
- OBIO N/A
- Industry
- ACNB Major Banks
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- ACNB Finance
- OBIO Health Care
- Exchange
- ACNB Nasdaq
- OBIO Nasdaq
- Market Cap
- ACNB 372.5M
- OBIO 205.0M
- IPO Year
- ACNB N/A
- OBIO N/A
- Fundamental
- Price
- ACNB $42.24
- OBIO $5.41
- Analyst Decision
- ACNB Buy
- OBIO Strong Buy
- Analyst Count
- ACNB 2
- OBIO 4
- Target Price
- ACNB $37.00
- OBIO $15.75
- AVG Volume (30 Days)
- ACNB 15.1K
- OBIO 45.0K
- Earning Date
- ACNB 10-29-2024
- OBIO 11-11-2024
- Dividend Yield
- ACNB 2.99%
- OBIO N/A
- EPS Growth
- ACNB N/A
- OBIO N/A
- EPS
- ACNB 3.66
- OBIO N/A
- Revenue
- ACNB $106,710,000.00
- OBIO $2,079,000.00
- Revenue This Year
- ACNB N/A
- OBIO $7.68
- Revenue Next Year
- ACNB $21.19
- OBIO $110.40
- P/E Ratio
- ACNB $11.68
- OBIO N/A
- Revenue Growth
- ACNB N/A
- OBIO N/A
- 52 Week Low
- ACNB $30.24
- OBIO $4.22
- 52 Week High
- ACNB $48.55
- OBIO $11.69
- Technical
- Relative Strength Index (RSI)
- ACNB 49.12
- OBIO 52.84
- Support Level
- ACNB $41.56
- OBIO $5.20
- Resistance Level
- ACNB $44.45
- OBIO $5.99
- Average True Range (ATR)
- ACNB 1.03
- OBIO 0.34
- MACD
- ACNB -0.00
- OBIO 0.10
- Stochastic Oscillator
- ACNB 40.05
- OBIO 53.60
About ACNB ACNB Corporation
ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Bank which generates the majority of the revenue provides banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.